Peter J. Barry

583 total citations
10 papers, 176 citations indexed

About

Peter J. Barry is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Ophthalmology. According to data from OpenAlex, Peter J. Barry has authored 10 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Psychiatry and Mental health and 2 papers in Ophthalmology. Recurrent topics in Peter J. Barry's work include Cystic Fibrosis Research Advances (5 papers), Retinal Imaging and Analysis (2 papers) and Neurological Complications and Syndromes (2 papers). Peter J. Barry is often cited by papers focused on Cystic Fibrosis Research Advances (5 papers), Retinal Imaging and Analysis (2 papers) and Neurological Complications and Syndromes (2 papers). Peter J. Barry collaborates with scholars based in Ireland, United Kingdom and United States. Peter J. Barry's co-authors include Eva M. Kohner, Ian Macdonald, I. H. L. Wallow, Suresh Chandra, Karla J. Johns, Colleen D. Bindley, Herman de Kock, Pavel Dřevı́nek, J.S. Elborn and K. De Boeck and has published in prestigious journals such as American Journal of Clinical Nutrition, Ophthalmology and Diabetologia.

In The Last Decade

Peter J. Barry

10 papers receiving 155 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter J. Barry 56 52 43 30 29 10 176
Sachin Mehta 51 0.9× 8 0.2× 33 0.8× 23 0.8× 76 2.6× 17 206
Ashish Nabar 12 0.2× 5 0.1× 23 0.5× 12 0.4× 43 1.5× 23 612
Christine Falk Klein 20 0.4× 3 0.1× 29 0.7× 34 1.1× 9 0.3× 8 100
Cheng‐I Wu 7 0.1× 8 0.2× 15 0.3× 11 0.4× 37 1.3× 21 264
Beom Soo Kim 33 0.6× 5 0.1× 12 0.3× 31 1.0× 32 1.1× 9 274
Deborah Conte Santos 31 0.6× 3 0.1× 20 0.5× 40 1.3× 21 0.7× 24 224
Arin Chatterjee 172 3.1× 3 0.1× 68 1.6× 85 2.8× 122 4.2× 12 330
V. Datta 8 0.1× 20 0.4× 4 0.1× 16 0.5× 49 1.7× 14 194
Andrew M. Schimel 332 5.9× 5 0.1× 78 1.8× 8 0.3× 58 2.0× 12 403
Mette H. Stensen 6 0.1× 12 0.2× 4 0.1× 19 0.6× 45 1.6× 19 313

Countries citing papers authored by Peter J. Barry

Since Specialization
Citations

This map shows the geographic impact of Peter J. Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Barry more than expected).

Fields of papers citing papers by Peter J. Barry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Barry. The network helps show where Peter J. Barry may publish in the future.

Co-authorship network of co-authors of Peter J. Barry

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Barry. A scholar is included among the top collaborators of Peter J. Barry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Barry. Peter J. Barry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bell, Scott C., Peter J. Barry, K. De Boeck, et al.. (2019). CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials. Journal of Cystic Fibrosis. 18(5). 700–707. 36 indexed citations
2.
Boeck, K. De, Pavel Dřevı́nek, Barry J. Plant, et al.. (2018). WS01.4 GLPG2222 in subjects with cystic fibrosis and the F508del/Class III mutation on stable treatment with ivacaftor: results from a phase II study (ALBATROSS). Journal of Cystic Fibrosis. 17. S2–S2. 6 indexed citations
3.
Nicholson, Trevor T., et al.. (2016). Relationship between pulmonary hyperinflation and dyspnoea severity during acute exacerbations of cystic fibrosis. Respirology. 22(1). 141–148. 9 indexed citations
4.
Barry, Peter J., Barry J. Plant, Nicholas J. Simmonds, et al.. (2013). 54 UK and Ireland review of ivacaftor in severe CF: Impact on hospitalisations and antibiotic use. Journal of Cystic Fibrosis. 12. S62–S62. 1 indexed citations
5.
Barry, Peter J., Barry J. Plant, Arjun Nair, et al.. (2013). WS7.6 UK and Ireland review of ivacaftor in severe CF: Impact on lung function and weight. Journal of Cystic Fibrosis. 12. S15–S15. 1 indexed citations
6.
Barry, Peter J., et al.. (2007). Novel Agents in the Management of Mycobacterium Tuberculosis Disease. Current Medicinal Chemistry. 14(18). 2000–2008. 37 indexed citations
7.
Cahill, Mark, Peter J. Barry, & Paul F. Kenna. (1998). GIANT RETINAL TEAR IN USHER SYNDROME TYPE II. Retina. 18(2). 177–177. 9 indexed citations
8.
Wallow, I. H. L., Karla J. Johns, Peter J. Barry, Suresh Chandra, & Colleen D. Bindley. (1985). Chorioretinal and Choriovitreal Neovascularization After Photocoagulation for Proliferative Diabetic Retinopathy. Ophthalmology. 92(4). 523–532. 18 indexed citations
9.
Kohner, Eva M. & Peter J. Barry. (1984). Prevention of blindness in diabetic retinopathy. Diabetologia. 26(3). 173–9. 50 indexed citations
10.
Macdonald, Ian & Peter J. Barry. (1964). Changes in the Fatty Acid Pattern of the Adipose Tissue of Obese Subjects while on a Reducing Regimen. American Journal of Clinical Nutrition. 15(3). 158–160. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026